A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Molecular Oncology (MONC) Program Bookmark and Share

Molecular Oncology (MONC) Program

Emily Wang, Ph.D., Co-leader
Binghui Shen, Ph.D., Co-leader
Program Members -If you would like an updated membership list, please contact Kim Lu at kilu@coh.org.
 
The overall scientific vision of theMolecularOncologyProgram (MONC)is to investigate fundamental DNA and RNA biology for the purpose of understanding basic mechanisms of cancer and ultimately identifying potential new therapeutic approaches. The major emphasis is on understanding the biology of cancer cells, which is accomplished by investigating the development of cancer, studying the biological mechanisms of cancer development, discovering information on key targets for cancer therapy, and developing advanced technologies used in cancer research.
 
Investigations into the mechanisms of DNA damage and repair mechanisms form one foundation of this program and are relevant to cancer development. Changes in cellular gene expression that accompany tumor growth are equally important to cancer progression. Studies of DNA methylation and epigenetics represent a second strong component of the program. Investigators studying transcriptional and post-transcriptional mechanisms of gene regulation contribute yet another dimension to this program. Changes in gene expression during cancer cell progression can result in a variety of events that promote uncontrolled cellular growth. These include altered splicing patterns and disregulation of the microRNA population, both of which lead to additional alterations in gene expression. Nuclear receptors and transcription factors have traditionally been important chemotherapeutic targets; theMolecular Oncologyprogram includes a group of investigators studying these important macromolecules and their ligands.

Program Goals
  • Understand the relationship between DNA damage and repair, mutagenesis, and carcinogenesis at the molecular level.
  • Investigate the fundamental processes underlying gene regulation, epigenetics and RNA biology during cell lineage commitment and tumor formation.
 
Members' Research
Members of theMolecular OncologyProgram have expertise in diverse areas of basic cancer biology that include chromatin structure, receptor-mediated control of gene expression, regulation of transcription by tissue- and cell-specific transcription factors, small drug interactions with and modulation of DNA and RNA function, cell signaling mechanisms, regulation of RNA processing, and the use of epigenetic tools such as siRNA and ribozymes to modulate gene expression. These basic science studies provide the foundation for future development of novel approaches to cancer therapy by the DCT, CI and HM Programs.
 

Molecular Oncology (MONC) Program

Molecular Oncology (MONC) Program

Emily Wang, Ph.D., Co-leader
Binghui Shen, Ph.D., Co-leader
Program Members -If you would like an updated membership list, please contact Kim Lu at kilu@coh.org.
 
The overall scientific vision of theMolecularOncologyProgram (MONC)is to investigate fundamental DNA and RNA biology for the purpose of understanding basic mechanisms of cancer and ultimately identifying potential new therapeutic approaches. The major emphasis is on understanding the biology of cancer cells, which is accomplished by investigating the development of cancer, studying the biological mechanisms of cancer development, discovering information on key targets for cancer therapy, and developing advanced technologies used in cancer research.
 
Investigations into the mechanisms of DNA damage and repair mechanisms form one foundation of this program and are relevant to cancer development. Changes in cellular gene expression that accompany tumor growth are equally important to cancer progression. Studies of DNA methylation and epigenetics represent a second strong component of the program. Investigators studying transcriptional and post-transcriptional mechanisms of gene regulation contribute yet another dimension to this program. Changes in gene expression during cancer cell progression can result in a variety of events that promote uncontrolled cellular growth. These include altered splicing patterns and disregulation of the microRNA population, both of which lead to additional alterations in gene expression. Nuclear receptors and transcription factors have traditionally been important chemotherapeutic targets; theMolecular Oncologyprogram includes a group of investigators studying these important macromolecules and their ligands.

Program Goals
  • Understand the relationship between DNA damage and repair, mutagenesis, and carcinogenesis at the molecular level.
  • Investigate the fundamental processes underlying gene regulation, epigenetics and RNA biology during cell lineage commitment and tumor formation.
 
Members' Research
Members of theMolecular OncologyProgram have expertise in diverse areas of basic cancer biology that include chromatin structure, receptor-mediated control of gene expression, regulation of transcription by tissue- and cell-specific transcription factors, small drug interactions with and modulation of DNA and RNA function, cell signaling mechanisms, regulation of RNA processing, and the use of epigenetic tools such as siRNA and ribozymes to modulate gene expression. These basic science studies provide the foundation for future development of novel approaches to cancer therapy by the DCT, CI and HM Programs.
 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Discover the wide range of progressive cancer treatment options at City of Hope designed to meet the individual needs of each patient. Here, medical research and clinical care are integrated, speeding the application of scientific discoveries toward better, more effective patient cancer treatments.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 
When you support City of Hope, you help us shorten the time it takes to get from bold, innovative ideas to powerful new medical treatments. Make a gift online now.


NEWS & UPDATES
  • The body’s immune system is usually adept at attacking outside invaders such as bacteria and viruses. But because cancer originates from the body’s own cells, the immune system can fail to see it as foreign. As a result, the body’s most powerful ally can remain largely idle against cancer as the disease progres...
  • On Jan. 1, 2015, five City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” Her...
  • Are you thinking about switching from traditional cigarettes to e-cigarettes for the Great American Smokeout? Are you thinking that might be a better option than the traditional quit-smoking route? Think again. For lung expert Brian Tiep, M.D., the dislike and distrust he feels for e-cigs comes down to this: Th...
  • Hematologist Robert Chen, M.D., is boosting scientific discovery at City of Hope and, by extension, across the nation. Just ask the National Cancer Institute. The institution recently awarded Chen the much-sought-after Clinical Investigator Team Leadership Award for boosting scientific discovery at City of Hope...
  • Great strides have been made in treating cancer – including lung cancer – but by the time people show symptoms of the disease, the cancer has usually advanced. That’s because, at early stages, lung cancer has no symptoms. Only recently has lung cancer screening become an option. (Read more about the risks...
  • Identifying cures for currently incurable diseases and providing patients with safe, fast and potentially lifesaving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I). The clinic is funded by an $8 million, five-year grant from the California Institute for Regene...
  • Cancer is a couple’s disease. It affects not just the person diagnosed, but his or her partner as well. It also affects the ability of both people to communicate effectively. The Couples Coping with Cancer Together program at City of Hope teaches couples how to communicate and solve problems as a unit. He...
  • Chemotherapy drugs work by either killing cancer cells or by stopping them from multiplying, that is, dividing. Some of the more powerful drugs used to treat cancer do their job by interfering with the cancer cells’ DNA and RNA growth, preventing them from copying themselves and dividing. Such drugs, however, l...
  • During October, everything seems to turn pink – clothing, the NFL logo, tape dispensers, boxing gloves, blenders, soup cans, you name it – in order to raise awareness for what many believe is the most dangerous cancer that affects women: breast cancer. But, in addition to thinking pink, women should...
  • In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. The pneumonia complicated what was already destined to be grueling treatment regimen. To assess the extent of her illness, Maya had to endure a spinal ...
  • Former smokers age 55 to 74 who rely on Medicare for health care services have just received a long-hoped-for announcement. Under a proposed decision from the Centers for Medicare and Medicaid Services, they’ll now have access to lung cancer screening with a low-dose CT scan. The proposed decision, announ...
  • City of Hope has a longstanding commitment to combating diabetes, a leading national and global health threat. Already, it’s scored some successes, from research that led to the development of synthetic human insulin – still used by millions of patients – to potentially lifesaving islet cell transplants. Diabet...
  • Dee Hunt never smoked. Neither did her five sisters and brothers. They didn’t have exposure to radon or asbestos, either. That didn’t prevent every one of them from being diagnosed with lung cancer. Their parents were smokers, but they’d all left home more than 30 years before any of them were diagn...
  • They may not talk about it, but women with cancers in the pelvic region, such as cervical cancer, bladder cancer and uterine cancer, often have problems controlling their urine, bowel or flatus. Although they may feel isolated, they’re far from alone. Many other women have such problems, too. In fact, nea...
  • Cancer that spreads to the liver poses a significant threat to patients, and a great challenge to surgeons. The organ’s anatomical complexity and its maze of blood vessels make removal of tumors difficult, even for specialized liver cancer surgeons. Following chemotherapy, the livers of cancer patients are not ...